About
ADCs
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Team (13)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
305
By Phase
PHASE1: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05872295Lead Sponsor
IKS014 in Advanced Solid Tumors That Express HER2
PHASE1Recruiting
165 participants
Started: Sep 14, 2023 · Completed: Sep 30, 2027
NCT05365659Lead Sponsor
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
PHASE1Recruiting
140 participants
Started: Sep 5, 2023 · Completed: Sep 30, 2028
Locations (1)
Headquarters
Newcastle, UK
Map
Loading map...